Wills F L, McCubbin W D, Gimona M, Strasser P, Kay C M
Department of Biochemistry, University of Alberta, Edmonton, Canada.
Protein Sci. 1994 Dec;3(12):2311-21. doi: 10.1002/pro.5560031216.
Native calponin is able to bind 2 mol of calcium binding protein (CaBP) per mole calponin. This study extends this observation to define the 2 domains of interaction, one of which is near the actin binding site, and the other in the amino-terminal region of calponin. Also, the first evidence for a differentiation in the response of calponin to interaction with caltropin versus calmodulin is demonstrated. The binding of caltropin to cleavage and recombinant fragments of calponin was determined by 3 techniques: tryptophan fluorescence of the fragments, CD measurements to determine secondary structure changes, and analytical ultracentrifugation. In order to delineate the sites of interaction, 3 fragments of calponin have been studied. From a cyanogen bromide cleavage of calponin, residues 2-51 were isolated. This fragment is shown to bind to CaBPs and the affinity for caltropin is slightly higher than that for calmodulin. A carboxyl-terminal truncated mutant of calponin comprising residues 1-228 (CP 1-228) has been produced by recombinant techniques. Analytical ultracentrifugation has shown that CP 1-228, like the parent calponin, is able to bind 2 mol of caltropin per mol of 1-228 in a Ca(2+)-dependent fashion, indicating that there is a second site of interaction between residues 52-228. Temperature denaturation of the carboxyl-terminal truncated fragment compared with whole calponin show that the carboxyl-terminal region does not change the temperature at which calponin melts; however, there is greater residual secondary structure with whole calponin versus the fragment. A second mutant produced through recombinant techniques comprises residues 45-228 and is also able to bind caltropin, thus mapping the location of the second site of interaction to near the actin binding site.
天然钙调蛋白每摩尔钙调蛋白能够结合2摩尔钙结合蛋白(CaBP)。本研究扩展了这一观察结果,以确定两个相互作用结构域,其中一个靠近肌动蛋白结合位点,另一个位于钙调蛋白的氨基末端区域。此外,还首次证明了钙调蛋白与刺槐毒素和钙调蛋白相互作用时反应的差异。通过三种技术测定了刺槐毒素与钙调蛋白的裂解片段和重组片段的结合:片段的色氨酸荧光、用于确定二级结构变化的圆二色性测量以及分析超速离心。为了确定相互作用位点,研究了钙调蛋白的三个片段。通过溴化氰裂解钙调蛋白,分离出了2 - 51位残基。该片段显示出与CaBPs结合,并且对刺槐毒素的亲和力略高于对钙调蛋白的亲和力。通过重组技术制备了包含1 - 228位残基的钙调蛋白羧基末端截短突变体(CP 1 - 228)。分析超速离心表明,CP 1 - 228与亲本钙调蛋白一样,能够以Ca(2+)依赖的方式每摩尔1 - 228结合2摩尔刺槐毒素,这表明在52 - 228位残基之间存在第二个相互作用位点。与完整钙调蛋白相比,羧基末端截短片段的温度变性表明,羧基末端区域不会改变钙调蛋白熔化的温度;然而,完整钙调蛋白与片段相比具有更大的残余二级结构。通过重组技术产生的第二个突变体包含45 - 228位残基,也能够结合刺槐毒素,从而将第二个相互作用位点的位置定位到靠近肌动蛋白结合位点处。